|
|
| A British Study of Cannabis (Circa 1910 AD) |
|
|
|
| |
|
| A critical review of the research literature concerning some biological and psychological effects of cannabis |
Dr. Peter L. Nelson |
| Cannabis and the law
in Queensland: A discussion paper. |
1993 |
| |
|
| A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology |
Eubanks et al. |
| Molecular Pharmaceutics
ASAP Article 10.1021/mp060066m |
9/8/06 |
| |
|
| A preliminary DTI study showing no brain structural change associated with adolescent cannabis use |
Delisi et al. |
| Harm Reduction Journal
2006, 3:17 (electronic publication ahead of print) |
9 May 2006 |
| |
|
| A Report of the National Commission on Ganja to the Prime Minister of Jamaica |
Prof. Barry Chevannes,
Chairman, et al |
| National Commission
on Ganja, Jamaica |
Aug 7, 2001 |
| |
|
| A Review of Drugs Policy and Proposals for the Future |
The Association of
Chief Police Officers |
| ACPO Drugs Committee |
April 2002 |
| |
|
| A Smoking Gun? The impact of cannabis smoking on respiratory health |
|
| The British Lung Foundation |
11/11/02 |
| |
|
| Acute effects of smoked marijuana and oral d-9-thc on specific airway conductance in asthmatic subjects |
Tashkin, Shapiro,
and Frank |
| American Review of
Respiratory Disease, Volume 109, p. 420-428 |
1974 |
| |
|
| Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study |
Coffey, Carlin, Lynskey,
Li and Patton |
| The British Journal
of Psychiatry 182: 330-336 |
2003 |
| |
|
| Adverse effects of cannabis |
Wayne Hall, Nadia
Solowij |
| The Lancet, vol. 352,
no. 9140, pp 1611-1616 |
14/11/98 |
| |
|
| After the War on Drugs - Options for Control |
Steve Rolles and Danny
Kushlick |
| Transform Drug Policy
Foundation |
12/10/04 |
| |
|
| Altered Minds - Cannabis and various graphs and tables |
|
| Channel 4 Citizen's
Commission on Drugs |
1998 |
| |
|
| Alternative systems of cannabis control in New Zealand - A discussion paper |
|
| Drug Policy Forum
Trust, Wellington |
July 1997 |
| |
|
| Alternative systems of cannabis control in New Zealand - References |
|
| Drug Policy Forum
Trust, Wellington |
July 1997 |
| |
|
| An endocannabinoid mechanism for stress-induced analgesia |
Hohmann et al. |
| Nature vol 435 p1108-1112 |
23/06/05 |
| |
|
| An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. |
Brady et al. |
| Multiple Sclerosis
10(4):425-33 |
August 2004 |
| |
|
| Analgesic and anti-inflammatory activity of constituents of Cannabis Sativa L. |
E.A. Formukong, A.T.
Evans, and F.J. Evans |
| Inflammation, Vol
12, No. 4 |
1988 |
| |
|
| Annual report on the state of the drugs problem in the European Union and Norway 2004 |
|
| European Monitoring
Centre for Drugs and Drugs Addiction (EMCDDA) |
25/11/04 |
| |
|
| Answers to frequently asked questions about marijuana use |
|
| The Drug Education
Project |
|
| |
|
| Anti-Tumor Effects |
GW Pharmaceuticals |
|
|
| |
|
| Antiemetic effect of Delta-9-Tetrahydrocannabinol in patients receiving Cancer Chemotherapy |
Sallan, Stephen E.,
Norman E. Zinberg, and Emil Frei. |
| New England Journal
of Medicine Vol. 293(16) 795-797. |
1975 |
| |
|
| Antineoplastic activity of cannabinoids |
Munson, Harris, Friedman,
Dewey and Carchman |
| Journal of the National
Cancer Institute v55 no. 3 |
September 1975 |
| |
|
| Anxiety with Depression Research Review |
Edward Glick |
| Oregon Medical Marijuana
Act Debilitating Medical Conditions Advisory Panel |
27/03/00 |
| |
|
| Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic re |
Campbell et al. |
| British Medical Journal
323(7303):13-6 |
07/07/01 |
| |
|
| Attributes of long-term heavy cannabis users: a case-control study |
Gruber, Pope, Hudson
and Yurgelun-Todd |
| Psychological Medicine,
33, 1415–1422. |
2003 |
| |
|
| Back To Chernobyl |
Lila Guterman |
| New Scientist |
10 April 1999 |
| |
|
| BMA report calls for change in law and development of new cannabis-based medicines |
|
| British Medical Association |
18/11/97 |
| |
|
| Body's 'cannabis' could hold blood pressure key |
|
| BBC Online |
Dec 29, 1998 |
| |
|
| Brain chemicals mimic marijuana |
Johnathon S. Choi |
| Reuters |
Aug 1997 |
| |
|
| Building Toward The Future With Hemp |
Conde & Seber |
| High Times |
July 1994 |
| |
|
| Business: Hemp's good habits |
|
| The Economist |
Aug 1, 1998 |
| |
|
| Cannabidiol and D9-tetrahydrocannabinol are neuroprotective antioxidants |
Hampson, Grimaldi,
Axelrod and Wink |
| Proceedings of the
National Academy of Sciences Vol. 95, pp. 8268–8273 |
July 1998 |
| |
|
| Cannabidiol: The Wonder Drug of the 21st Century? |
|
|
|
| |
|
| Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse |
J H Allen, G M de
Moore, R Heddle and J C Twartz |
| Gut 2004;53:1566-1570 |
November 2004 |
| |
|
| Cannabinoids and Brain Injury |
Mechoulam, Panikashvili,
Shohami |
| TRENDS in Molecular
Medicine Vol.8 No.2 |
February 2002 |
| |
|
| Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients |
Volfe Z., Dvilansky
A., Nathan I. |
| Int J Clin Pharm.
Res V (4) 243-246 |
1985 |
| |
|
| Cannabinoids control spasticity and tremor in a multiple sclerosis model |
David Baker, et al. |
| Nature |
20 Jan 2000 |
| |
|
| Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review |
Tramer et al. |
| British Medical Journal
2001;323:1–8 |
7/7/01 |
| |
|
| Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study) |
Zajicek et al. |
| Lancet 2003; 362:
1517–26 |
2003 |
| |
|
| Cannabinoids on the Brain |
Andrew J. Irving,
Mark G. Rae, Angela A. Coutts |
| TheScientificWorldJOURNAL
(2002) 2, 632-648 |
2002 |
| |
|
| Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects |
Jiang et al. |
| Journal of Clinical
Investigation [Electronic publication ahead of print] |
13/10/05 |
| |
|
| Cannabinoids: Potential Anticancer Agents |
Manuel Guzman |
| Nature Reviews |
1 Oct 2003 |
| |
|
| Cannabis (the Wootton Report) |
Advisory Committee
On Drug Dependence |
| The Home Office |
01/11/68 |
| |
|
| Cannabis - An update 1999 - 2002 |
Professor DJ Nutt
& Dr JR Nash |
| Psychopharmacology
Unit, University of Bristol |
March 2002 |
| |
|
| Cannabis - Government Response |
The House of Lords,
Science and Technology Committee |
|
4 March 1999 |
| |
|
| Cannabis - our position for a Canadian public policy |
Pierre Claude Nolin
(Chair) |
| The Senate Special
Committee on Illegal Drugs (Canada) |
September 2002 |
| |
|
| Cannabis amotivational syndrome and personality trait absorption: A review and reconceptualization |
Peter L. Nelson, Ph.D. |
| Imagination, Cognition
and Personality, 14(1), 43-58. |
1994-5 |
| |
|
| Cannabis and driving |
University of Adelaide
and Transport SA |
| Australian Press |
21 October 199 |
| |
|
| Cannabis and harm reduction |
Wendy Swift, Jane
Copeland, Simon Lenton |
| Drug and Alcohol Review
(2000) 19, 101-112 |
2000 |
| |
|
| Cannabis and Health |
Michael Farrell and
Bruce Ritson |
| The British Journal
of Psychiatry (2001) 178: 98 |
2001 |
| |
|
| Cannabis and pregnancy |
Balle J, Olofsson
MJ, Hilden J |
| Ugeskr Laeger 161(36):5024-8 |
06/09/99 |
| |
|
| Cannabis and Psychiatric Pathology: An update |
Luis Dominguez |
| The Journal of Applied
Research vol. 4 no. 1 |
2004 |
| |
|
| Cannabis and road safety - an outline of the research studies to examine the effects of cannabis on driving |
Dr G. B. Chesher |
| National Drug and
Alcohol Research Centre University of New South Wales |
|
| |
|
| Cannabis and schizophrenia: results of a follow-up study |
Dieter Caspari |
| European Archives
of Psychiatry and Clinical Neuroscience 249 :45–49 |
1999 |
| |
|
| Cannabis and the brain |
Leslie Iversen |
| Brain vol 126 p1252-1270. |
2003 |
| |
|
| Cannabis and Tobacco Smoke are not Equally Carcinogenic |
Robert J Melamede |
| Harm Reduction Journal
2005, 2:21 |
18/10 /05 |
| |
|
| Cannabis and tobacco: responding to claims made by the British Lung Foundation and related news coverage |
|
| Action on Health and
Smoking |
November 2002 |
| |
|
| Cannabis antagonists: a new era of social psychopharmacology? |
Nutt, D. |
| Journal of Psychopharmacology
19(1):3-4. |
January 2005 |
| |
|
| Cannabis effects and dependency concerns in long-term frequent users |
Andrew D. Hathaway,
Ph.D. |
| Under peer review
for the journal 'Addiction' |
2002 |
| |
|
| Cannabis for migraine treatment: The once and future prescription? An historical and scientific review |
Russo E. |
| Pain 1998;76(1-2):3-8. |
1998 |
| |
|
| Cannabis in Africa |
|
| Geopolitical Drugs
Dispatch |
1998/99 |
| |
|
| Cannabis in Asia |
|
| Geopolitical Drugs
Dispatch |
1998/99 |
| |
|
| Cannabis in Europe |
|
| Geopolitical Drugs
Dispatch |
1998/99 |
| |
|
| Cannabis in the Americas |
|
| Geopolitical Drugs
Dispatch |
1998/99 |
| |
|
| Cannabis intoxication and fatal road crashes in France: population based case-control study |
Bernard Laumon, Blandine
Gadegbeku, Jean-Louis Martin, Marie-Berthe Biechel |
| British Medical Journal
2005; 331: 1371 |
10/12/2005 |
| |
|
| Cannabis Policy, Implementation and Outcomes |
van het Loo, Hoorens,
van 't Hof, Kahan |
| RAND Europe |
2003 |
| |
|
| Cannabis report of the Swiss Federal Commission for Drug Issues (EKDF) |
|
| Swiss Federal Commission
for Drug Issues |
May 1999 |
| |
|
| Cannabis treatments in Obstetrics and Gynecology: A historical review |
Ethan Russo |
| Journal of Cannabis
Therapeutics Vol. 2, No. 3/4, p5-35 |
2002 |
| |
|
| Cannabis Use and Cognitive Decline in Persons under 65 Years of Age |
Constantine G. Lyketsos,
Elizabeth Garrett, Kung-Yee Liang, and James C. An |
| American Journal of
Epidemiology Vol. 149, No.9 pages 794-800 |
1 May 1999 |
| |
|
| Cannabis Use and Dependence in a New Zealand Birth Cohort |
David Ferguson and
John Horwood |
| New Zealand Medical
Journal 113 (1109): 1506-1508 |
12/05/00 |
| |
|
| Cannabis use and mental health in secondary school children: Findings from a Dutch survey |
Monshouwer et al. |
| The British Journal
of Psychiatry (2006) 188: 148-153 |
February 2006 |
| |
|
| Cannabis use and mental health in young people: cohort study |
G C Patton, C Coffey,
J B Carlin, L Degenhardt, M Lynskey, W Hall |
| The British Medical
Journal vol 325 p 1195 |
23/11/02 |
| |
|
| Cannabis use and misuse prevalence among people with psychosis |
Bob Green, Ross Young
and David Kavanagh |
| The British Journal
of Psychiatry (2005) 187: 306-313 |
2005 |
| |
|
| Cannabis use and psychosis: a longitudinal population-based study |
van Os J, Bak M, Hanssen
M, Bijl RV, de Graaf R, Verdoux H |
| American Journal of
Epidemiology 156(4):319-27 |
15/08/02 |
| |
|
| Cannabis use and psychosis: a review of clinical and epidemiological evidence |
Wayne Hall and Louisa
Degenhardt |
| Australian and New
Zealand Journal of Psychiatry 34(1): 26-34 |
February 2000 |
| |
|
| Cannabis use and pyschosis |
Wayne Hall |
| Problematic Alcohol
& Drug Use & Mental Illness, Melbourne |
February 1998 |
| |
|
| Cannabis use and the risk of later schizophrenia: a review |
Filip Smit, Linda
Bolier & Pim Cuijpers |
| Addiction Vol. 99
Issue 4 Page 425 |
April 2004 |
| |
|
| Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study |
L Arseneault, M Cannon,
R Poulton, R Murray, A Caspi, T Moffitt |
| The British Medical
Journal vol 325 p 1212 |
23/11/02 |
| |
|
| Cannabis use is associated with schizotypy and attentional disinhibition |
Patrick D. Skosnika,
Lea Spatz-Glenna, Sohee Park |
| Schizophrenia Research
48 (2001) 83-92 |
2001 |
| |
|
| Cannabis use predicts future psychotic symptoms, and vice versa |
Ferdinand et al. |
| Addiction 100(5):605-11. |
May 2005 |
| |
|
| Cannabis use to enhance sportive and non-sportive performances among French sport students |
Lorente at al. |
| Addictive Behaviors
30(7):1382-91 |
August 2005 |
| |
|
| Cannabis use, a stepping stone to other drugs? The case of Amsterdam |
Peter Cohen &
Arjan Sas |
| CEDRO Centre for Drug
Research, University of Amsterdam |
1997 |
| |
|
| Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds |
Gieringer, St. Laurent,
Goodrich |
| Journal of Cannabis
Therapeutics, Vol. 4(1) |
2004 |
| |
|
| Cannabis – Proposals for a Harm Reduction Strategy |
J. Ditchfield, S.
Lucas Brewer |
|
Oct 04, revise |
| |
|
| Cannabis, cannabinoids and reproduction |
Boram Park, John McPartland
and Michelle Glass |
| Prostaglandins, Leukotrienes
and Essential Fatty Acids 70 189–197 |
2004 |
| |
|
| Cannabis, Cognition, and Residual Confounding |
Harrison G. Pope,
Jr, MD |
| Journal of the American
Medical Association 2002;287 no. 9 |
06/03/02 |
| |
|
| Cannabis, social control and exclusion: the importance of social ties |
Amnon J. Suissa |
| International Journal
of Drug Policy Vol 12, 5-6, pp 385-396 |
01/11/01 |
| |
|
| Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases |
Arendt M, Rosenberg
R, Foldager L, Perto G, Munk-Jorgensen P. |
| British Journal of
Psychiatry 2005 Dec;187:510-5. |
December 2005 |
